Let us help you customize your experience.
Tell us a little about yourself so we can share more relevant content and resources.
This study investigates the safety, tolerability and effectiveness of daily peanut oral immunotherapy treatment in children 1 to 3 years of age over the course of approximately 1 year. The total duration of the study is approximately 24 months. Compensation will be provided.
Must be between 1 and 3 years of age, and have a physician documented peanut allergy.